AHA president has asked Congress to intervene and demand HHS take a position on “drug companies’ attempts to hijack the 340B ...

Drugmaker Eli Lilly and Co. is restricting access to a drug discount program intended for safety-net hospitals in a move the ...

Nonprofit healthcare centers are lobbying for a special exemption from a new Health and Human Services reimbursement review ...

A federal judge on Monday temporarily blocked the U.S. administration’s planned 340B Rebate Model Pilot Program, finding that regulators likely failed to meet basic administrative law requirements ...

A clear look at the 340B program: how hospitals generate revenue from drug discounts, why it has expanded, and the growing ...

After years of investigation, the outgoing chairman of the Senate Health, Education, Labor and Pensions Committee has ...

Targeted transparency requirements, clearer guidance on contract pharmacy use, and stronger duplicate-discount safeguards ...

Policies written with the best intentions can be misinterpreted or misused. This is especially true if proper oversight is lacking or if new policy creates unforeseen opportunities. I believe this is ...

Congress needs to act to bring needed reforms into the 340B to make revenue from the drug pricing program more transparent and to ensure patients are benefiting from the discounts, according to a ...

It's time for Congress to bring stronger accountability to 340B and ensure that the program actually serves its intended ...